<http://webisa.webdatacommons.org/238310255>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<genengnews.com> .
<http://webisa.webdatacommons.org/prov/113864982>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/238310255> .
<http://webisa.webdatacommons.org/238310255>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/238310255>	<http://www.w3.org/ns/prov#value>	"???We are pleased that the NIMH has again awarded a grant to support our orphan GPCR research, comments Gregory A. Demopulos, M.D., chairman, and CEO. ???Omeros??? DTLacO platform can generate antibodies that target a wide range of diseases, including multiple types of cancer." .